Evidence map›Paper›PMID 27006843›Full record

ArticleCase reports in obstetrics and gynecology2016

Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature.

Minakshi Rohilla, Bharti Joshi, Vanita Jain, Jasvinder Kalra, G R V Prasad

Open access · goldAbstract read
In one paragraph

Article in Case reports in obstetrics and gynecology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.American journal of respiratory and critical care medicine · 2019
    Guideline
  2. Review
  3. Review
  4. Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy.European journal of drug metabolism and pharmacokinetics · 2021
    Review
  5. Review
  6. Management of drug-resistant tuberculosis.Lancet (London, England) · 2019
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Minakshi RohillaDepartment of Obstetrics & Gynaecology, PGIMER, Chandigarh 160012, India.
Bharti JoshiDepartment of Obstetrics & Gynaecology, PGIMER, Chandigarh 160012, India.
Vanita JainDepartment of Obstetrics & Gynaecology, PGIMER, Chandigarh 160012, India.
Jasvinder KalraDepartment of Obstetrics & Gynaecology, PGIMER, Chandigarh 160012, India.
G R V PrasadDepartment of Obstetrics & Gynaecology, PGIMER, Chandigarh 160012, India.
Post Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant tuberculosis (MDR-TB) is identified from the time of introduction of antituberculosis treatment and is a known worldwide public health crisis affecting women of reproductive age group. Management issues raised by pregnant women with MDR tuberculosis are challenging due to the limited clinical experience available with the use of second line drugs. We hereby report two cases of MDR-TB during pregnancy: one patient was on second line drugs, while another one was evaluated and diagnosed to have MDR-TB in last trimester. At 6 months of follow-up both mothers and babies are doing well. The approach to such cases along with review of the literature is discussed.

Identifiers

PMID27006843
PMCPMC4783553
OpenAlexW2280403086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.